Radiation
RadiationSubjects to receive standard of care CT scan and additional Cone Beam CT scan.
NCT Number: NCT01855425
The study objective is to compare the CBCT images generated by the CS 9300 to those generated by conventional CT.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Sint-Augustinus Hospital, Antwerp, Belgium
The study objective is to compare the CBCT images generated by the CS 9300 to those generated by conventional CT. It proposes a direct comparison of diagnostic image quality between the CS 9300 and CT for the ability to view and confirm ENT disorders.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects to receive standard of care CT scan and additional Cone Beam CT scan.
Time frame: 11 months
Percentage of Participants with >=3 Diagnostic Rating Using Radlex Scale. Five radiologists participated in reader study using Radlex scale below to analyze and rate participant images. They determined if they could make a medical diagnosis for ENT patients.
Used Radlex Scale - 1-Non-diagnostic, Unacceptable for diagnostic purposes. 2-Limited Acceptable, with some technical defect. 3-Diagnostic, Image quality that would be expected routinely when imaging cooperative patients. 4-Exemplary, Good most adequate for diagnostic purposes.
Carestream Health, Inc.
Industry
Cone Beam CT (CS 9300) for Diagnosis of Select Otorhinolaryngology (ENT) Indications at Lower Dose
Acronym: CBCT-ENT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07411690
Astrocytoma, Brain Diseases
Warsaw, Poland
View Trial DetailsNCT07216157
Brain Diseases, Brain Neoplasms
Warsaw, Poland
View Trial DetailsNCT06711731
Brain Diseases, Central Nervous System Diseases
Freiburg im Breisgau, Germany
View Trial DetailsNCT02019888
Cholesteatoma, Ear Diseases
Portland, Oregon, United States
View Trial Details